2. Definition
“A primary disorder of the heart muscle that causes
abnormal myocardial performance and is not the
result of disease or dysfunction of other cardiac
structures …
myocardial infarction,
systemic hypertension,
valvular stenosis or
regurgitation”
3. WHO Classification
Unknown cause
(primary)
Dilated
Hypertrophic
Restrictive
Specific heart muscle
disease (secondary) due
to a known cause:
Infective
Metabolic
Systemic disease
Herediofamilial
Sensitivity
Toxic(alcohol)
4. Functional Classification
Dilated (congestive, DCM, IDC)
ventricular enlargement and syst dysfunction
Hypertrophic (IHSS, HCM, HOCM)
inappropriate myocardial hypertrophy
in the absence of HTN or aortic stenosis
Restrictive (infiltrative)
abnormal filling and diastolic function
5. We are going to cover….
1. dilated cardiomyopathy (DCM)
2. hypertrophic cardiomyopathy (HCM)
3. restrictive cardiomyopathy (RCM)
And in addition…
4. arrhythmogenic right ventricular dysplasia (ARVD)
5. obliterative cardiomyopathy (OCM)
8. Idiopathic Dilated Cardiomyopathy
a disease of unknown etiology that principally affects
the myocardium
LV dilatation and systolic dysfunction
pathology
increased heart size and weight
ventricular dilatation, normal wall thickness
heart dysfunction out of portion to fibrosis
10. Incidence and Prognosis
3-10 cases per 100,000
20,000 new cases per year in the U.S.A.
death from progressive pump failure
1-year 25%
2-year 35-40%
5-year 40-80%
stabilization observed in 20-50% of patient
complete recovery is rare
11.
12. Symptoms.
Symptoms of heart failure
Due to pulmonary congestion (left HF)
dyspnea (rest, exertional, nocturnal), orthpnea
Due to systemic congestion (right HF)
edema, nausea, abdominal pain, nocturia
Due to low cardiac output
fatigue and weakness
13. Clinical Signs.
Pulsus alternans
Pulsus tardus
Systolic blood pressure normal or less than normal.
Raised JVP
Prominent a and v waves tricuspid regurgitation
b/l basal crepts
Pedal edema
Hepatomegaly
Gallop rhythm
Systolic murmurs—Mitral,tricuspid reg.
14. Findings on ECG
Sinus tachycardia in presence of heart failure.
Atrial and ventricular tachyarryhthmias
Poor r wave progression
Anterior q waves
Intaventricular conduction defects –mostly LBBB
Left atrial abnormality
Hypertensive changes by voltage criteria not evident
ST –T changes are seen.
16. Findings on 2D Echo.
Dilated chambers
Left atrium is usualy enlarged
Left ventricle is enlarged.normal 3.8—5.0cm
Mitral and tricuspid regurgitation on doppler flow.
LV or Global hypokinesia with an LVEF of <45%
Stress testing --tachyarryhthmias
Dobutamine stress echo helpful in assessing the clinical
prognosis.
17. Treatment—
ACE,
B blockers in symptomatic,
Diuretics- vol. overload,
Spironolactone –advanced,
Digoxin is drug of choice,
Treatment of arrhythmias.
Biventricular pacing—plus ICDs—IVCDS,
Anticoagulation,
Amiodarone,
20. HCM: Incidence
Most common cause of sudden death in young
athletes.
Prevalence approx. 100 per 1 lakh population
Characterized by in appropriate and elaborate LV
hypertrophy with misalignment of the myocardial
fibres.
Hypertrophy may be generalized or confined largely to
interventricular septum.
21. Pathophysiology
Heart failure may develop because stiff non-compliant
ventricles impede systolic filling.
Septal hypertrophy may cause dynamic LV outflow
obstruction.
Mitral regurgitation occur due to abnormal systolic
anterior mitral valve leaflet.
22.
23. Clinical Features
Symptoms…. S A D
Syncope on effort/pre-syncope
Angina on effort
Dyspnea on effort
Sudden death (SCD)
(less frequent )…palpitations, PND, dizziness
Signs
Jerky pulse
Palpable LV heave
Double impulse at apex
mid-systolic murmur –sign of LV outflow obstruction
Pansystolic murmur
24. Risk factors for SCD
Young age (<30 years)
“Malignant” family history of sudden death
Gene mutations prone to SCD (ex. Arg403Gln)
Aborted sudden cardiac death
Sustained VT or SVT
Recurrent syncope in the young
Nonsustained VT (Holter Monitoring)
Brady arrhythmias (occult conduction disease)
25. Treatment
B-blocker and rate-limiting calcium antagonists (eg.
verapamil)
No pharmacological treatment is known to improve
prognosis
Arrhythmia is common and responds well to amiodarone.
Outflow tract obstruction can be improved by
partial surgical resection (myectomy) or
iatrogenic infarction of basal septum (septal ablation)
Implantable cardiac defibrillation (ICD) for patient with
risk of sudden death.
28. Background
Rare condition
Ventricular filling is impaired because ventricles are
stiff.
Lead to high atrial pressure with atrial hypertrophy,
dilatation and later atrial fibrillation.
Amyloidosis is the most common cause.
Other form:
Idiopathic perimyocyte fibrosis
Familial restrictive cardiomyopathy
29. Clinical Features
Symptoms of right and left heart failure
Jugular Venous Pulse
prominent x and y descents
Echo-Doppler
abnormal mitral inflow pattern
prominent E wave (rapid diastolic filling)
reduced deceleration time ( LA pressure)
30. Differential diagnosis
Hallmark: abnormal diastolic function due to a rigid
ventricular wall with impaired ventricular filling.
Bear some functional resemblance to constrictive
pericarditis.
Importance lies in its differentiation from operable
constrictive pericarditis
31. Restrictive v/s Constrictive
History provide can important clues
Constrictive pericarditis
history of TB, trauma, pericarditis, collagen vascular
disorders
Restrictive cardiomyopathy
amyloidosis, hemochromatosis
Mixed
mediastinal radiation, cardiac surgery
32. Diagnosis and Treatment.
Diagnosis is difficult
Require complex Doppler echocardiography
CT and MRI and endomyocardial biopsy may be done.
No satisfactory medical therapy
Drug therapy must be used with caution
diuretics for extremely high filling pressures
vasodilators may decrease filling pressure
? Calcium channel blockers to improve diastolic compliance
digitalis and other inotropic agents are not indicated
Transplantation is the best treatment
33. Arrhythmogenic Right Ventricular Dysplasia
In this condition, patches of the right ventricular myocardium
are replaced with fibrous and fatty tissue.
Inherited as autosomal dominant trait
Prevalence in India is 10 per 1 lakh population.
Dominant clinical problems are
ventricular arrhythmia
Sudden death
Right sided cardiac failure
ECG shows inverted T waves in the right precordial leads.
MRI useful diagnostic tool and used to screen 1st degree
relatives from having the same pathology.
34. Obliterative Cardiomyopathy
It is also rare in India.
Involves the endocardium of one or both ventricles and is
characterized by thrombosis and elaborate fibrosis with
gradual obliteration of the ventricular cavities.
Mitral and tricuspid valves are regurgitant.
Heart failure and pulmonary and systemic embolism are
prominent.
Anticoagulation and antiplatelet therapy is advisable and
diuretics may help symptoms of HF.
Surgery valve replacement with decortication of
endocardium may be helpful in certain cases.
36. References:
Harrison 18th Edtn.
Braunwald heart disease 8th Edtn.
Hurst Heart 12th Edtn.
Jr. of the American Heart Association.
British Medical Jr.
Google.com for images.